Development and biological evaluation of AzoBGNU: A novel hypoxia-activated DNA crosslinking prodrug with AGT-inhibitory activity

Title
Development and biological evaluation of AzoBGNU: A novel hypoxia-activated DNA crosslinking prodrug with AGT-inhibitory activity
Authors
Keywords
chloroethylnitrosoureas, tumor targeting, hypoxia-activated prodrug, DNA interstrand crosslinks, drug resistance, O, -alkylguanine DNA alkyltransferase
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 144, Issue -, Pages 112338
Publisher
Elsevier BV
Online
2021-10-22
DOI
10.1016/j.biopha.2021.112338

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now